Endometriosis: Symptoms, Causes, Risk Factors & Treatment Options

Endometriosis—endometrial-like tissue outside the uterus—affects ~10% of reproductive-age women (190M globally). It's not just "bad periods"; it's a chronic, systemic, inflammatory disease with profound quality-of-life impact. Average diagnostic delay: 7–10 years.

Pathophysiology

  • Retrograde menstruation (Sampson) + immune clearance failure + peritoneal metaplasia + stem cell dissemination + lymphatic/vascular spread.
  • Lesions: peritoneal (superficial, deep infiltrating/DIE), ovarian endometriomas ("chocolate cysts"), extra-pelvic (bowel, bladder, diaphragm, lung, CNS).
  • Estrogen-dependent, progesterone-resistant, pro-inflammatory, angiogenic, neurogenic (nerve ingrowth → pain).

Symptom Spectrum

  • Pain: Dysmenorrhea (progressive), chronic pelvic pain, deep dyspareunia, dyschezia (bowel), dysuria (bladder), cyclic shoulder tip pain (diaphragmatic).
  • Infertility: 30–50% of endo patients; 25–50% of infertility patients have endo. Mechanisms: inflammation, anatomy distortion, oocyte quality, implantation.
  • Fatigue, bloating ("endo belly"), nausea, cyclic GI/GU symptoms.
  • Comorbidities: Adenomyosis, fibroids, IBS, IC/BPS, migraine, autoimmune, depression/anxiety, central sensitization.

Risk Factors

  • Early menarche, short cycles (<27 d), heavy flow, nulliparity
  • Family history (6–9x if 1st-degree relative)
  • Müllerian anomalies (outflow obstruction)
  • Low BMI (paradoxical)
  • Environmental: dioxins, PCBs (endocrine disruptors)

Diagnosis

  • Clinical suspicion + exam (uterosacral nodularity, fixed retroverted uterus, adnexal mass).
  • Imaging: Transvaginal US (endometriomas, DIE nodules), MRI (surgical mapping). Normal imaging ≠ no endo.
  • Gold standard: Laparoscopy + histopathology. But diagnostic laparoscopy no longer required to start treatment (ESHRE 2022).

Treatment: Multimodal, Individualized

Medical (Suppress Estrogen / Modulate Inflammation)

  • NSAIDs (first-line pain)
  • Combined OCP / Progestin-only (pill, IUD, implant, injection) — continuous cycling preferred
  • GnRH agonists (leuprolide) + add-back (E2/MPA) — ≤12 mo
  • GnRH antagonists (elagolix, relugolix) — oral, dose-titratable, no add-back needed
  • Dienogest (progestin, approved in many countries)
  • Aromatase inhibitors (off-label, specialist)

Surgical

  • Excision (gold standard) vs. ablation — lower recurrence, better pain/fertility outcomes.
  • Fertility-sparing: cystectomy (endometriomas), DIE resection (bowel/bladder shaving/resection), adhesiolysis.
  • Definitive: Hysterectomy ± BSO (last resort, after childbearing). Ovarian preservation preferred <45.

Adjunctive

  • Pelvic floor PT (hypertonicity, trigger points)
  • Diet: Anti-inflammatory, low-FODMAP (if IBS overlap)
  • Mind-body: CBT, mindfulness, yoga (central sensitization)
  • Acupuncture (some evidence)
  • Specialist multidisciplinary team (gyn, colorectal, urology, pain, PT, psych).

Fertility Considerations

  • Surgery before IVF: improves natural conception, but may reduce ovarian reserve (endometriomas).
  • IVF outcomes: slightly lower per cycle, but cumulative live birth similar.
  • Freeze-all + delayed transfer if fresh endometriosis flare.

Endometriosis is a whole-person condition. You deserve a clinician who believes you, investigates thoroughly, and treats holistically.

Infertility - Related Articles